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Abstract 
A range of epidemiological. clinical and experimental studies have demonstrated 
that exposure of an embryo to a suboptimal environment in vivo or ex vivo during 
early embryo development is associated with altered development of 
cardiovascular, neuroendocrine and metabolic disorders in adult life. A number 
of perturbations during early embryo development result in developmental 
adaptations by the embryo to ensure immediate survival. whilst programming the 
embryo for altered fetal and placental development, resulting in the eventual 
onset of adult disease. It has been previously shown that maternal nutrient 
restriction during the periconceptional period results in a hyperactivation of the 
pituitary - adrenal axis and increased mean arterial blood pressure in twin but not 
singleton pregnancies. 
It was therefore the first aim of this thesis to interrogate the impact of maternal 
undernutrition during the periconceptional period (defined as from at least 45 
days prior until 7 days after conception) on fetal and placental development 
during early pregnancy at - day 55 of pregnancy, which coincides with the period 
of maximal placental growth. In Chapter 2, it has been demonstrated that there 
are important relationships between maternal weight gain during the 
periconceptional period and feto-placental growth during the first - 55 days of 
pregnancy and that periconceptional undernutrition has a differential effect on 
these relationships in singleton and twin pregnancies. In singleton pregnancies, 
periconceptional undernutrition disrupts the relationship between maternal weight 
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gain d�ring the periconceptional period and utero-placental growth and in twin 
pregnancies, periconceptional undernutrition results in the emergence of an 
inverse relationship between maternal weight gain during early pregnancy and 
uteroplacental growth and in a dependence of fetal growth on placental growth. 
(Chapter 2) 
In order to investigate the origins of the physiological adaptations that lead to the 
development of hyperactivation of the pituitary - adrenal axis and increased 
mean arterial blood pressure in late gestational fetuses after exposure as an 
embryo to periconceptional undernutrition, we investigated the development and 
steroidogenic capacity of the fetal adrenal gland and development of the fetal 
heart and kidney at - 55 days gestation (Chapter 3 and 4). 
The relative weight of the fetal adrenal and adrenal IGF-1, IGF-1 R, IGF-2, IGF-
2R and CYP 17 mRNA expression were lower in twin compared to singleton 
fetuses. There was evidence that in control singletons, IGF-2R expression plays 
an important role in the regulation of adrenal growth and CYP 17 mRNA 
expression during early pregnancy. In control twins, however, whilst there was a 
significant positive relationship between adrenal CYP 17 and IGF-2 mRNA 
expression, adrenal weight was directly related to the level of adrenal IGF-1 
mRNA expression. There was no effect of periconceptional undernutrition on the 
level of expression of any of the placental or adrenal genes in the study. In PCUN 
ewes, carrying singletons, however, there was a loss of the relationships between 
either adrenal IGF-2, IGF-2R and IGF-1 mRNA expression and adrenal growth 
and CYP 17 expression which were present in control singletons. Similarly in 
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ewes carrying twins, maternal undernutrition during the periconceptional period 
resulted in the loss of the relationships between adrenal growth and IGF-1 
expression and between _ adrenal CYP 17 and IGF-2 expression which were 
present in control twin fetuses. Whilst there was no effect of fetal number on 
fetal heart growth at - d55 in twin fetuses, there was a direct relationship 
between relative fetal heart and adrenal weights, which was present in both the 
PCUN and control groups. There was also a significant inverse relationship 
between maternal weight at conception and relative fetal heart weight in PCUN 
twin, but not PCUN singleton or control fetuses (Chapter 3). 
In control pregnancies maternal weight gain during the periconceptional period is 
inversely related to the relative weight of the fetal kidney at -55d pregnancy. In 
this group, relative kidney weight was also directly related to renal IGF-1 mRNA 
expression. In control twins maternal weight gain was inversely related to fetal 
kidney weight and this effect was ablated when the effects of maternal cortisol 
was controlled for in the analysis. In the PCUN group, whilst there was an inverse 
relationship between maternal weight gain during the periconceptional period and 
relative kidney weight, it was not possible to separate the independent effects of 
maternal weight loss during the periconceptional period and the subsequent 
weight gain during the period of refeeding. Renal IGF-1 mRNA expression was 
higher and renal lGF-1 R and 2R expression were lower in twin fetuses compared 
to singletons. After exposure to PCUN, renal IGF-1 expression was also higher 
than in control pregnancies independent of the fetal number (Chapter 4). 
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Superovulation, artificial inseminatiQn, embryo transfer and in vitro embryo 
culture are used in a range of assisted reproductive technologies, and it has been 
demonstrated that varying the composition of the culture media can result in a 
change in pre and postnatal development. Culture of sheep embryos in media 
containing serum is associated with fetal overgrowth which is phenotypic of the 
Large Offspring Syndrome. It is not known how the combination of 
superovulation, artificial insemination and embryo transfer alone impacts feto­
placental development in late gestation of the sheep. There have been no 
studies, however, examining the differential impact of superovulation, artificial 
insemination and embryo transfer with or without in vitro embryo culture in the 
absence or presence of human serum on feto-placental development in Singleton 
and twin pregnancies (Chapter 5). 
I have therefore tested the hypothesis that superovulation, artificial insemination 
and embryo transfer with or without in vitro embryo culture in the presence or 
absence of human serum differentially alters the growth of the placenta, fetus 
and fetal organs during late gestation when compared to naturally conceived 
controls and that these effects are different in singleton and twin pregnancies. 
The fetal weight, CRL and abdominal circumference were significantly larger in 
IVCHS singleton fetuses. A novel finding in this study was lower fetal weights of 
twin fetuses in the ET and IVCNS groups compared to NM control twin fetuses. 
In addition, placental weights were lighter in twin fetuses in the ET, IVCNS and 
IVCHS treatment groups and this is partially due to a failure to initiate 




The results of this thesis therefore highlight the complex interactions between the 
periconceptional environment (in vivo or ex vivo) and embryo or fetal number on 
the programming fetal and placental development. Maternal undernutrition 
during the periconceptional period and superovulation, artificial insemination and 
embryo transfer with or without in vitro culture in the absence or presence of 
serum alters fetal development, and I have demonstrated that these changes in 
fetal growth can be explained by changes in placental growth trajectory. 
Furthermore, a novel finding of this study is that perturbations of the 
periconceptional environment affect feto-placental development differently in 
singleton and twin pregnancies. 
